Tag:

Quintiles

Latest Headlines

Latest Headlines

Basilea picks Quintiles to move its antibiotic in Europe

Basilea Pharmaceutica ran into an FDA roadblock in its efforts to commercialize a new antibiotic, but the Swiss drug developer already has a green light in Europe, and it's tapping Quintiles' global marketing expertise to launch the treatment on its home continent.

Quintiles extends its commercial capabilities with Encore buyout

Quintiles has wrapped up its acquisition of healthcare analytics provider Encore, part of the CRO's push to grow its post-market services.

Quintiles partners up to flex its commercial muscles

Quintiles believes in better drug sales through data analytics, signing a deal with a marketing-optimization company to pool resources and figure out how to better reach physicians on behalf of its commercialization clients.

Quintiles signs an expansive deal to chart effects of physical therapy

Quintiles, the world's largest CRO, is lending its Big Data heft to the American Physical Therapy Association, agreeing to help create a registry of patient outcomes data to inform future treatment.

Quintiles targets healthcare providers with its latest buy

Quintiles, the world's largest CRO, is further expanding its outside-the-clinic business, agreeing to buy healthcare analytics outfit Encore Health Resources to beef up its access to real-world patient data.

Quintiles keeps rolling with another $1B quarter

Quintiles, the world's largest CRO, hit the $1 billion service revenue threshold for the second time last quarter, piling up new business wins with eyes on its biggest year ever.

Biogen brings Quintiles to the R&D table in 5-year pact

Biogen Idec has struck up a far-reaching agreement with CRO giant Quintiles, tapping the contractor to help design, plan and run its Phase II-IV studies.

Biogen and Quintiles ink a deep-seated deal to boost R&D efficiency

Going well beyond the standard sponsor-CRO relationship, Biogen Idec has recruited Quintiles to revamp its clinical development process, giving the contractor a seat at the R&D table to improve trial efficiency.

Quintiles taps OmniComm for early-stage data management

Global CRO Quintiles is reaching out to software provider OmniComm to replace its Phase I eClinical technology, signing a 5-year deal with the Florida company.

Quintiles signs on to help BioDelivery get its anti-addiction drug out the door

Raleigh, NC's BioDelivery Sciences is expecting to win FDA approval for its opioid-dependence patch this summer, and the biotech has enlisted global contractor Quintiles to handle the launch.